[1]
F. Öztürk Ergür, M. Yıldız, M. U. Şener, S. Kavurgacı, and A. Ozturk, “Adverse effects associated with favipiravir in patients with COVID-19 pneumonia: a retrospective study”, Sao Paulo Med J, vol. 140, no. 3, pp. 372–377, May 2022.